Peripheral vascular devices are medical devices used to diagnose and treat disorders affecting blood vessels outside the heart and brain. These devices help restore blood flow through narrowed or blocked vessels, treat arterial plaque, repair aneurysms, and manage blood clots. Their growing use is closely associated with the increasing adoption of minimally invasive endovascular procedures.

The major types of peripheral vascular devices include peripheral stents, angioplasty balloons, plaque modification devices, endovascular aneurysm repair (EVAR) stent grafts, catheters, guidewires, peripheral accessories, and inferior vena cava (IVC) filters. These devices enable physicians to perform vascular interventions through minimally invasive access, helping reduce surgical trauma, recovery time, and hospitalization requirements.

The Peripheral Vascular Devices Market size was valued at US$ 14.24 billion in 2025 and is projected to reach US$ 22.45 billion by 2033, expanding at a CAGR of 5.86% from 2026 to 2033. The market is experiencing steady growth as the global burden of peripheral vascular diseases increases and healthcare providers increasingly adopt minimally invasive treatment approaches. Rising cases of peripheral arterial disease (PAD), diabetes, obesity, hypertension, and age-related vascular disorders are generating sustained demand for advanced devices used in diagnosis and treatment.

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗮𝗴𝗲𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:https://www.businessmarketinsights.com/sample/BMIPUB00032463 

Peripheral Vascular Devices Market Overview

The growing prevalence of vascular disorders is one of the primary factors supporting the expansion of the Peripheral Vascular Devices Market. Peripheral arterial disease is particularly important because its prevalence increases with age and is closely associated with diabetes, smoking, hypertension, and other cardiovascular risk factors.

At the same time, healthcare providers are increasingly favoring minimally invasive procedures because they can offer shorter recovery periods, reduced hospitalization requirements, and improved patient comfort compared with conventional surgical approaches.

Manufacturers are responding to these trends through continued product innovation. Drug-eluting balloons and stents, advanced plaque modification technologies, intravascular lithotripsy systems, and next-generation delivery systems are expanding treatment options for complex vascular lesions.

Key Trends in the Peripheral Vascular Devices Market

Increasing Adoption of Minimally Invasive Procedures

One of the most important trends shaping the market is the increasing use of minimally invasive endovascular interventions. Catheters, guidewires, balloons, stents, and other devices enable physicians to treat vascular blockages through relatively small access points.

The advantages associated with these procedures, including reduced recovery time and potentially shorter hospital stays, are contributing to their growing adoption.

Technological Advancements in Vascular Devices

Technological innovation is transforming peripheral vascular interventions. Drug-eluting balloons and drug-eluting stents are designed to deliver therapeutic agents to targeted vascular areas, while advanced plaque modification technologies help physicians manage complex and calcified lesions.

Intravascular lithotripsy is another emerging technology that can facilitate the treatment of heavily calcified vessels. Continued innovation is expected to support the development of more precise, efficient, and patient-focused vascular interventions.

Shift Toward Outpatient Treatment

Healthcare systems are increasingly exploring outpatient and ambulatory treatment models to control costs and improve resource utilization. The shift of selected peripheral vascular procedures toward ambulatory surgical centers can create additional opportunities for device manufacturers.

As procedural technologies become more efficient and healthcare providers gain experience with outpatient interventions, demand for compact and easy-to-use peripheral vascular devices is expected to increase.

Peripheral Vascular Devices Market Drivers

Rising Prevalence of Peripheral Arterial Disease

The increasing incidence of peripheral arterial disease (PAD) is a major driver of the Peripheral Vascular Devices Market. PAD is associated with narrowing or blockage of arteries and can significantly impair blood circulation in the limbs.

The growing geriatric population, increasing prevalence of diabetes, obesity, hypertension, and sedentary lifestyles are contributing to the expansion of the patient population requiring vascular diagnosis and intervention.

As the number of patients requiring treatment rises, demand for angioplasty, stenting, atherectomy, and other peripheral vascular procedures is expected to increase.

Growing Geriatric Population

Age is an important risk factor for peripheral vascular disease. As populations age across developed and developing countries, the number of individuals susceptible to vascular disorders is increasing.

Healthcare systems are therefore experiencing greater demand for vascular screening, diagnosis, and intervention. This demographic shift is expected to create a long-term growth opportunity for peripheral vascular device manufacturers.

Increasing Demand for Advanced Endovascular Technologies

The growing preference for less invasive treatment options is encouraging healthcare providers to adopt advanced endovascular technologies. Devices that improve lesion crossing, vessel preparation, drug delivery, and stent deployment can improve procedural capabilities and expand treatment options.

This technological progression is expected to remain an important contributor to market growth through 2033.

Peripheral Vascular Devices Market Opportunities

Expansion of Ambulatory Surgical Centers

The increasing adoption of outpatient care presents an important opportunity for market participants. Ambulatory surgical centers can provide selected vascular interventions while reducing dependence on traditional inpatient hospital infrastructure.

Manufacturers developing devices that support efficient, predictable, and minimally invasive procedures can benefit from this transition.

Growth Opportunities in Asia-Pacific

The Asia-Pacific Peripheral Vascular Devices Market represents a significant growth opportunity due to expanding healthcare infrastructure, increasing healthcare expenditure, rising diabetes prevalence, and growing awareness of advanced vascular treatments.

Countries such as China, India, Japan, South Korea, and Australia are investing in healthcare infrastructure and advanced medical technologies. These developments are expected to support the adoption of peripheral vascular devices across the region.

Development of Next-Generation Devices

Continuous research and development provides opportunities for manufacturers to introduce more sophisticated vascular devices. Improvements in device flexibility, deliverability, lesion-crossing capability, drug delivery, and vessel preparation can address unmet clinical needs and strengthen competitive positioning.

Peripheral Vascular Devices Market Restraints

Despite favorable growth prospects, several factors may limit market expansion. Stringent regulatory requirements and high clinical trial costs can increase the time and investment required to commercialize new devices.

Product recalls, device failures, and safety concerns can also affect market confidence and increase compliance requirements. In addition, advanced peripheral vascular procedures often require highly trained specialists. A shortage of experienced vascular surgeons and interventional specialists in certain regions may limit the adoption of sophisticated technologies.

The relatively high cost of advanced devices can also present challenges for healthcare providers and patients, particularly in price-sensitive emerging markets.

Peripheral Vascular Devices Market Segmentation

The Peripheral Vascular Devices Market is segmented based on product type, indication, and end user.

By Product Type

• Peripheral Stents
• Endovascular Aneurysm Repair Stent Grafts
• Plaque Modification Devices
• Peripheral Accessories
• Inferior Vena Cava Filters
• Others

Peripheral stents represent a significant product category because of their widespread use in treating narrowed or blocked peripheral arteries. Continued improvements in stent design, flexibility, deliverability, and clinical performance are supporting demand.

By Indication

• Peripheral Arterial Disease
• Peripheral Aneurysms or Aortic Aneurysms
• Deep Vein Thrombosis (DVT)
• Arteriovenous Fistulas
• Others

Peripheral arterial disease represents an important application area due to the large patient population affected by arterial narrowing and reduced blood flow.

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

Hospitals remain key end users because they provide comprehensive infrastructure for complex vascular interventions. However, specialty clinics and ambulatory surgical centers are expected to gain importance as outpatient and minimally invasive treatment models expand.

Regional Outlook for the Peripheral Vascular Devices Market

The global Peripheral Vascular Devices Market is analyzed across North America, Europe, Asia-Pacific, South and Central America, and the Middle East and Africa.

North America

North America benefits from advanced healthcare infrastructure, high healthcare expenditure, established vascular intervention centers, and strong adoption of innovative medical technologies. The region's aging population and prevalence of diabetes and cardiovascular risk factors also support demand for peripheral vascular interventions.

Europe

Europe represents an important market supported by its aging population, sophisticated healthcare systems, reimbursement infrastructure, and increasing adoption of minimally invasive vascular procedures. Countries such as Germany, France, the United Kingdom, Italy, and Spain contribute significantly to regional demand.

Asia-Pacific

Asia-Pacific is expected to offer substantial growth opportunities over the forecast period. Increasing diabetes prevalence, improving healthcare infrastructure, rising healthcare expenditure, and growing awareness of advanced vascular treatments are supporting market development.

South and Central America

The market in South and Central America is supported by improving healthcare infrastructure and increasing access to advanced diagnostic and interventional procedures. Brazil, Argentina, Chile, Colombia, and Peru represent important markets within the region.

Middle East and Africa

The Middle East and Africa market is supported by healthcare modernization initiatives, investments in medical infrastructure, and increasing access to specialized cardiovascular and vascular care. Growing healthcare expenditure in several Gulf countries is also creating opportunities for advanced medical device adoption.

Competitive Landscape

The Peripheral Vascular Devices Market is competitive, with major medical technology companies focusing on product development, strategic partnerships, distribution expansion, and portfolio diversification.

Key companies operating in the market include:

• Abbott
• Medtronic
• Teleflex Incorporated
• Cook
• Cordis
• Boston Scientific Corporation
• W. L. Gore & Associates, Inc.
• Biotronik
• BD
• Terumo Corporation

These companies are focusing on technological innovation and expansion of their peripheral vascular product portfolios to strengthen their positions in the global market.

Recent Developments in the Peripheral Vascular Devices Market

In October 2025, Medtronic announced the full distribution of the Neuroguard IEP System following a successful limited market distribution. The development followed Medtronic's earlier announcement of an exclusive US distribution agreement with Contego Medical.

In December 2024, Terumo Interventional Systems announced the launch and commercial availability of its R2P NaviCross peripheral support catheter in the US. The 200 cm catheter expanded Terumo's radial-to-peripheral portfolio and was designed to provide improved trackability and torque control during lesion-crossing procedures.

Future Outlook

The future of the Peripheral Vascular Devices Market is expected to be shaped by the convergence of rising disease prevalence, aging populations, minimally invasive treatment preferences, and medical technology innovation.

The increasing use of drug-eluting technologies, plaque modification systems, intravascular lithotripsy, advanced stents, and improved catheter technologies is likely to expand the range of vascular conditions that can be treated through endovascular approaches.

The transition toward outpatient procedures and the growing healthcare investment in emerging economies, particularly across Asia-Pacific, could further create opportunities for manufacturers.

According to Business Market Insights, the market is projected to increase from US$ 14.24 billion in 2025 to US$ 22.45 billion by 2033, representing a 5.86% CAGR from 2026 to 2033.